Abuse and Addiction in ICU
NCT02951793 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-08-20
Summary
Investigators are seeking to determine the impact of recent alcohol, smoking or psychotropic drug use prior to intensive care unit (ICU) admission on incidence of delirium and sedation requirements.
Study design: A prospective observational study, in a medical ICU of a tertiary university hospital.
Methods: For all new ICU admissions, a 1-page questionnaire including Alcohol Use Disorders Identification Test (AUDIT-C), smoking history and prior medication use was given to the patient or closest family members.
Delirium was assessed by trained ICU nurses using Intensive Care Delirium Screening Checklist and Richmond Agitation-Sedation Scale.
Conditions
- Substance Withdrawal Syndrome
Interventions
- OTHER
-
AUDIT-C
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including AUDIT-C about his/her alcohol behavior during last year and will be categorized into two groups: Those with AUDIT-C\>4 versus AUDIT-C of 4 or below.
- OTHER
-
Smoking history
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including smoking history during last year and will be categorized into two groups: Current smoker versus ex- or never smoker (we also recorded smoking pack-years to distinguish heavy smokers)
- OTHER
-
Prior psychotropic medication use
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including psychotropic medication use prior admission to ICU and will be categorized into two groups: Those who use psychotropic medication versus those who do not use psychotropic medication.
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Jinwoo Lee, Professor · Seoul National University Hospital
-
Jungsil Lee, M.D. · Seoul National University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
NCT02299921 ·Status: RECRUITING
-
Severe Alcohol-use Disorder: a tDCS and Response Inhibition Training Intervention
NCT03447054 ·Status: COMPLETED ·Phase: NA
-
Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16
NCT00000264 ·Status: COMPLETED ·Phase: NA
-
Antioxidant Replacement Therapy in Patients With Alcohol Abuse
NCT00936000 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of THC on Alcohol Consumption and Neural Correlates of Reward
NCT06446479 ·Status: RECRUITING ·Phase: PHASE2
-
Cognitive Retraining and Brain Stimulation for Alcohol Use
NCT02045108 ·Status: COMPLETED ·Phase: NA
-
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal
NCT02823977 ·Status: WITHDRAWN ·Phase: PHASE4
-
Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
NCT02322047 ·Status: COMPLETED ·Phase: PHASE2
-
Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
NCT00936377 ·Status: COMPLETED ·Phase: NA
-
Study of Addiction Criteria in the Elderly
NCT03509077 ·Status: UNKNOWN
-
Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU
NCT02723383 ·Status: COMPLETED ·Phase: PHASE3
-
Inpatient Alcohol Detox & Psychotherapy
NCT03988478 ·Status: COMPLETED ·Phase: NA
-
Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder
NCT02570763 ·Status: WITHDRAWN ·Phase: NA
-
Treatment of Alcohol Withdrawal in Hospital Patients
NCT00249366 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Cannabis on Dementia Related Agitation and Aggression
NCT03328676 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Center Retrospective Cohort Study of Auto-intoxicated Patients Admitted to the ICU
NCT05933421 ·Status: COMPLETED
-
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040 ·Status: RECRUITING ·Phase: PHASE1
-
Single and Dual Task Balance Exercises in Substance Use Disorders
NCT05944536 ·Status: UNKNOWN ·Phase: NA
-
The Behavioral Effects of Opioids and Alcohol
NCT04300751 ·Status: COMPLETED ·Phase: PHASE1
-
Amplification of Positivity for Alcohol Use
NCT06030154 ·Status: RECRUITING ·Phase: NA
-
PT150 Drug for Use in Alcohol Use Disorder
NCT06712602 ·Status: RECRUITING ·Phase: PHASE1
-
Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
NCT02058251 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study.
NCT00614328 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin and Alcohol Withdrawal and Dependence
NCT02903251 ·Status: COMPLETED ·Phase: PHASE3